Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 59 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9029550

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 12, 2015 · Expires May 7, 2035

    granted
  2. US 9023340

    Wnt inhibitors for human stem cell differentiation

    ChemRegen, Inc. · Granted May 5, 2015 · Expires Apr 30, 2035

    granted
  3. US 9023858

    Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 5, 2015 · Expires Apr 30, 2035

    granted
  4. US 9023356

    Treatment method using EGFR antibodies and SRC inhibitors and related formulations

    The Regents of the University of California · Granted May 5, 2015 · Expires Apr 30, 2035

    granted
  5. US 9018201

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted
  6. US 9000025

    Autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  7. US 9000191

    Serotonin reuptake inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  8. US 8999982

    Pharmaceutically active compounds as Axl inhibitors

    Lead Discovery Center GmbH · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  9. US 9000179

    Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

    The Board of Regents of the University of Texas System · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  10. US 8999934

    Treatment of astrocytes-tumor cells inhibitors of endothelin receptors

    The Board of Regents of the University of Texas System · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  11. US 8999988

    Protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  12. US 8999987

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  13. US 8993585

    Cyclic amine substituted pyrimidinediamines as PKC inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted
  14. US 8993752

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted
  15. US 8987454

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  16. US 8987294

    Small molecule inhibitors of the α4-paxillin interaction

    The Regents of the University of California · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  17. US 8980838

    Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted
  18. US 8980902

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted
  19. US 8969359

    Gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  20. US 8969360

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  21. US 8969356

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  22. US 2015057294

    1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS

    ACRAF [IT] · Granted Feb 26, 2015 · Expires Feb 21, 2035

    granted
  23. US 8962642

    5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  24. US 8961959

    Glucosylceramide synthase inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted